Our studies present important evidence for a mechanism that controls RAS activity via regulation of its protein stability involving tumorigenesis and suggest that a mechanism regulating RAS stability via WDR76 may lead to development of strategies against human cancer. This evidence concerns the gene WDR76 and cancer.